Fact: paxalisib was bought in as a PII GBM asset ( go read the announcement) management the decided to go back and re-do a PI study. blew thru an extra $5-8 mil and wasted 8 months.
Wint bore you with intermediate facts DYOR
Fact: Kazia did a cap raise in Jan-Feb based on 4 milestones by June 30th.
Fact: 1week before all data read outs are due they suddenly added 6 months to most of the read out times...
You think Ross et al did well???? 0/4!!!!!
- Forums
- ASX - By Stock
- KZA
- Ann: Paxalisib receives Fast Track Designation from US FDA
Ann: Paxalisib receives Fast Track Designation from US FDA, page-16
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)